NSAIDs in COVID-19, friend or foe?

  • Reham Mahrous
  • Amr Abdelnasser
  • Raghda Fouda
  • Mohamed Abd Al Moniem Morsy
  • Omnia Mandour
DOI: https://doi.org/10.35975/apic.v27i1.2123
Keywords: COVID-19, pandemic, NSAIDs

Abstract

At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.

Key words: COVID-19; pandemic; NSAIDs

Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123

Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022

Author Biographies

Reham Mahrous

Cairo University, Cairo, Egypt

Amr Abdelnasser

Cairo University, Cairo, Egypt

Raghda Fouda

Cairo University, Cairo, Egypt

Mohamed Abd Al Moniem Morsy

Cairo University, Cairo, Egypt

Omnia Mandour

Egypt

Published
01-31-2023
How to Cite
Mahrous, R., Abdelnasser, A., Fouda, R., Moniem Morsy, M., & Mandour, O. (2023). NSAIDs in COVID-19, friend or foe?. Anaesthesia, Pain & Intensive Care, 27(1), 119-122. https://doi.org/10.35975/apic.v27i1.2123
Issue
Vol 27 No 1 (2023): February 2023
Section
NARRATIVE REVIEW

Most read articles by the same author(s)